CA
BLRX

Cetera Advisors’s BioLineRX BLRX Stock Holding History

Cetera Advisors’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$11.8K Buy
+264
New +$13.2K ﹤0.01% 2409

Other funds holding BLRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Cetera Advisors's BLRX Position: Q1 2024 in Review

Cetera Advisors opened a new position in BioLineRX (BLRX) in Q1 2024: 264 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #2409 among its holdings.

29 funds tracked by Wall St. Rank hold BLRX as of Q1 2024.

  • Cetera Advisors held 264 shares of BioLineRX worth $11.8K as of Q1 2024.
  • BioLineRX was a new Cetera Advisors position in Q1 2024.
  • BioLineRX made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2409 holding.
  • 29 funds tracked by Wall St. Rank held BioLineRX as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.